For fiscal 2025 (ended Dec 31, 2025), TORM plc reported $1.34B of revenue and $285.30M of net income.
TRMD revenue was $1.34B for fiscal 2025 (ended Dec 31, 2025), down 14.1% from fiscal 2024. Compound annual growth was +12.4% over 5 years and +9.5% over 10 years. It rose in 3 of the last 5 fiscal years.
TRMD net income was $285.30M for fiscal 2025 (ended Dec 31, 2025), down 53.4% from fiscal 2024. Compound annual growth was +26.5% over 5 years and +8.5% over 10 years. It rose in 1 of the last 3 fiscal years.
TRMD diluted EPS was $2.85 for fiscal 2025 (ended Dec 31, 2025), down 55.2% from fiscal 2024. Compound annual growth was +19.1% over 5 years and +1.7% over 10 years.
TRMD free cash flow was $190.40M for fiscal 2025 (ended Dec 31, 2025), down 22.1% from fiscal 2024. Compound annual growth was +24.9% over 5 years. It rose in 0 of the last 3 fiscal years.
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.34B | $1.56B | $1.52B | $1.44B | $619.50M | $747.40M | - | - | - | - |
| Selling, general and admin | $113.80M | $95.60M | $82.90M | $55.00M | $51.54M | $50.77M | $47.72M | $47.83M | $45.01M | $41.41M |
| Operating income | $356.30M | $658.80M | $698.60M | $601.50M | $1.40M | $138.91M | $205.89M | $2.82M | $39.53M | -$107.21M |
| Interest expense | $74.40M | $74.10M | $60.90M | $48.80M | $42.38M | $49.91M | $41.88M | $39.30M | $40.60M | $37.33M |
| Pre-tax income | $295.20M | $609.50M | $652.00M | $556.70M | -$40.74M | $89.53M | $166.81M | -$33.22M | $3.18M | -$141.73M |
| Income tax | $9.20M | -$2.00M | $4.00M | -$5.90M | $1.34M | $1.42M | $784.0K | $1.56M | $777.0K | $760.0K |
| Net income | $285.30M | $612.50M | $648.30M | $562.80M | -$42.09M | $88.11M | $166.00M | -$34.80M | $2.40M | -$142.50M |
| EPS, basic | $2.91 | $6.54 | $7.75 | $6.92 | -$0.54 | $1.19 | $2.24 | -$0.48 | $0.04 | -$2.27 |
| EPS, diluted | $2.85 | $6.36 | $7.48 | $6.80 | -$0.54 | $1.19 | $2.24 | -$0.48 | $0.04 | -$2.27 |
| Diluted shares | 100.1M | 96.3M | 86.7M | 82.8M | 78.4M | 74.3M | 74.0M | 73.1M | 62.0M | 62.9M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $158.10M | $271.90M | $265.50M | $320.50M | $144.80M | $89.51M | $56.85M | $124.09M | $132.95M | $74.12M |
| Inventory | $66.50M | $68.40M | $61.70M | $72.00M | $48.81M | $22.46M | - | - | - | - |
| Current assets | $531.90M | $615.30M | $691.20M | $739.70M | $363.32M | $243.66M | $215.91M | $269.30M | $261.45M | $181.28M |
| Goodwill | $1.80M | $1.70M | $1.80M | $1.80M | $0 | $0 | - | $0 | $0 | $0 |
| Total assets | $3.37B | $3.47B | $2.87B | $2.61B | $2.33B | $2.00B | $2.00B | $1.71B | $1.65B | $1.57B |
| Current liabilities | $401.40M | $285.40M | $265.40M | $206.40M | $307.19M | $196.71M | $194.94M | $167.12M | $156.13M | $151.80M |
| Short-term debt | $288.80M | $165.30M | $172.70M | $117.10M | $208.95M | $102.86M | - | - | - | - |
| Long-term debt | $714.30M | $1.06B | $886.90M | $849.80M | $926.45M | $739.54M | $756.35M | $655.16M | $651.60M | $595.70M |
| Total debt | $1.00B | $1.23B | $1.06B | $966.90M | $1.14B | $842.40M | $756.35M | $655.16M | $651.60M | $595.70M |
| Total liabilities | $1.16B | $1.39B | $1.20B | $1.11B | $1.28B | $981.17M | $996.19M | $867.19M | $855.52M | $790.68M |
| Shareholders' equity | $2.20B | $2.07B | $1.66B | $1.50B | $1.05B | $1.02B | $1.01B | $847.21M | $791.05M | $780.58M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $498.90M | $826.80M | $805.00M | $502.00M | $47.95M | $235.80M | $171.09M | $70.74M | $109.84M | $171.14M |
| Capital expenditures | $308.50M | $582.40M | $509.70M | $119.30M | $319.79M | $173.05M | $384.35M | $202.44M | $145.11M | $119.41M |
| Free cash flow | $190.40M | $244.40M | $295.30M | $382.70M | -$271.84M | $62.75M | -$213.26M | -$131.70M | -$35.27M | $51.73M |
| Investing cash flow | -$152.60M | -$442.10M | -$370.60M | $11.30M | -$290.59M | -$119.80M | -$322.82M | -$175.59M | -$113.73M | -$119.41M |
| Financing cash flow | -$460.10M | -$378.30M | -$489.40M | -$337.60M | $297.98M | -$83.33M | $84.49M | $95.99M | $62.72M | -$145.61M |
| Dividends paid | $199.70M | $553.30M | $586.40M | $166.70M | $0 | $70.61M | - | - | $1.24M | $25.00M |
| Share repurchases | - | - | - | - | - | $1.35M | - | - | - | - |
| Stock-based compensation | $34.10M | $30.20M | $22.50M | $2.20M | $2.30M | $1.70M | $1.90M | $2.00M | $1.90M | $2.00M |
| Depreciation and amortization | $214.50M | $192.00M | $149.30M | $139.00M | $130.85M | $121.92M | - | - | - | - |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | -14.1% | 2.6% | 5.3% | 133.0% | -17.1% | - | - | - | - | - |
| Net income growth, YoY | -53.4% | -5.5% | 15.2% | - | - | -46.9% | - | - | - | - |
| EPS growth, YoY | -55.2% | -15.0% | 10.0% | - | - | -46.9% | - | - | - | - |
| Operating margin | 26.6% | 42.3% | 45.9% | 41.7% | 0.2% | 18.6% | - | - | - | - |
| Net margin | 21.3% | 39.3% | 42.6% | 39.0% | -6.8% | 11.8% | - | - | - | - |
| Free cash flow margin | 14.2% | 15.7% | 19.4% | 26.5% | -43.9% | 8.4% | - | - | - | - |
| Return on equity | 13.0% | 29.5% | 39.0% | 37.4% | -4.0% | 8.7% | 16.5% | -4.1% | 0.3% | -18.3% |
| Return on assets | 8.5% | 17.7% | 22.6% | 21.5% | -1.8% | 4.4% | 8.3% | -2.0% | 0.1% | -9.1% |
| Current ratio | 1.33 | 2.16 | 2.60 | 3.58 | 1.18 | 1.24 | 1.11 | 1.61 | 1.67 | 1.19 |
| Debt to equity | 0.46 | 0.59 | 0.64 | 0.64 | 1.08 | 0.83 | 0.75 | 0.77 | 0.82 | 0.76 |
Source: XBRL data TORM plc files with the SEC, latest filing dated Feb 26, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
Foreign private issuers file annual reports with the SEC, so there are no quarterly statements here.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| TRMD | $1.34B | -14.1% | $285.30M | 21.3% | $3.55B |
| GD | $56.52B | +9.7% | $4.66B | 8.2% | $97.84B |
| RCL | $19.13B | +9.7% | $4.55B | 23.8% | $90.13B |
| CCL | $27.59B | +5.2% | $3.14B | 11.4% | $41.43B |
| VIK | $6.50B | +21.9% | $1.15B | 17.7% | $38.86B |
| BIP | $23.10B | +9.8% | $2.53B | 11.0% | $18.16B |
| HII | $13.53B | +12.6% | $733.00M | 5.4% | $11.99B |
| FRO | $1.97B | -8.8% | $379.08M | 19.2% | $9.86B |
| NCLH | $10.16B | +4.9% | $832.94M | 8.2% | $8.46B |